Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Finasteride safely reduces excessive hair growth in women.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Finasteride and metformin both help treat PCOS, but using them together works best.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.